Financials
Preliminary results for the year ended 31 Dec 2023 | May. 07, 2024 |
Trading Update | Jan. 22, 2024 |
Half Yearly Report | Sep. 29, 2023 |
Preliminary results for the year ended 31 Dec 2022 | May. 05, 2023 |
Trading Update | Jan. 10, 2023 |
Eden Half Yearly Report | Sep. 30, 2022 |
Trading Update | Aug. 22, 2022 |
Proxies
Result of AGM | Jun. 27, 2024 |
AGM Statement | Jun. 27, 2024 |
Publication of Annual Report and Notice of AGM | Jun. 05, 2024 |
Result of AGM | Jun. 30, 2023 |
AGM Statement | Jun. 29, 2023 |
Publication of Annual Report and Notice of AGM | Jun. 07, 2023 |
Result of AGM | Jun. 29, 2022 |
Ownership Update
Director/PDMR Shareholding | Jul. 10, 2024 |
Grant of Awards Under Long-Term Incentive Plan | Jul. 05, 2024 |
Holding(s) in Company | Jan. 19, 2024 |
Grant of Awards under Long-Term Incentive Plan | Aug. 31, 2023 |
Holding(s) in Company | Jun. 09, 2023 |
Holding(s) in Company | Jun. 05, 2023 |
Holding(s) in Company | Oct. 03, 2022 |
Announcements
Nematicide Approval in Greece | Sep. 02, 2024 |
Appointment of new Head of Regulatory Affairs | Aug. 15, 2024 |
Biofungicide regulatory authorisation in Germany | Aug. 13, 2024 |
Appointment of Global Product and Marketing Lead | Jul. 17, 2024 |
Bioinsecticide Field Trials | Jun. 27, 2024 |
Biofungicide Label Extension in Spain | Jun. 24, 2024 |
Eden Research wins at Small Cap Network Awards | Jun. 17, 2024 |